TEHRAN, Sep. 06 (MNA) � Biotechnology Research Center (Zist Fanavari) has launched development of 3 recombinant medicines including for MS and Alzheimer�s disease.

Azin Mehrdad, the head of Biotechnology Research Center in Iranian Research Organization�for�Science�and Technology told Mehr News that the Center was working on development of three medicines from herbal recombinant products. �Calcitonin Recombinant�Protein is a hormonal medicine which helps calcium sedimentation in bones and thus may function in preventing osteoporosis, which has recently been in rise across the country. �The research to develop the medicine had been launched 5 years ago; however, problems delayed the production of the medicine,� he added.


�The Research Center seeks to develop recombinant MGF (Mechano Growth Factor); the medicine is administered for patients with brain cell and neurons loss, such as Alzheimer�s and MS diseases,� Mehrdad said, adding that the medicine was in its experimental phase yet.


�Testing medicines on human, animal and cell culture is time consuming and needs human volunteers; we launched research on MGF 18 months ago,� Mehrdad said.


�According to figures by Ministry of Health, cervical cancer is on rise among women, where a virus is the major contributing factor; to fight the virus, in cooperation with Pasteur Institute, the Center is working on a vaccine to treat this cancer,� he maintained. �The vaccine is mandatory for female teens above 14 in the EU, while in Iran it is imported and we should produce the vaccine inside the country,� he added.


By Mehr News Agency





The Iran Project is not responsible for the content of quoted articles.